AWARDPURCHASE ORDERSmall business
Purchase order 75N95023P00436SINO BIOLOGICAL US INC.
Overview
Award facts
- Net obligations
- $54.7K
- $54,700of $54.7K potential value
- Outlays (paid to date)
- $41.4K
- $41.4K paid of $54.7K obligated$41,400
- Period of performance
- Jul 21, 2023 to Mar 19, 2024
- Ended
- Modifications
- 1
- Latest action Oct 25, 2023
- Contract type
- Purchase order
- PIID 75N95023P00436
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
ANTIVIRAL DRUG DEVELOPMENT OF HYBRIDOMA CELL LINES AND ANTIBODY FOR VIRAL ANTIGENS
Dates and value
- Award date
- Signed on Jul 17, 2023
- Potential end of performance
- Mar 18, 2024
- Current value
- $54,700Base and exercised options
- Potential value (if all options are exercised)
- $54,700
Obligations by fiscal year of action
- FY2024: -$10,800 (de-obligation)
- FY2023: $65,500
Total across 2 fiscal years: $54,700
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Oct 25, 2023. View on USAspending · Recipient on SAM.gov
Recipient
LocationCHESTERBROOK, PA
UEIGVLNLKK92321
CAGE code8D9V2
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companySINO BIOLOGICAL US INC.
Business types and certifications
Self-certified small disadvantaged businessForeign-ownedFor-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIDA
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NCATS
- Funded from
- National center for advancing translational sciences (0875)Program activities075-0875Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Chesterbrook, Chester County, Pennsylvania 19087-5525
- Congressional district (place of performance)
- PA-06As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Not competed under SAPG
- Reason not competed
- SAP non-competition (FAR 13)SP2
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- 75N95023Q00378
- Solicitation date
- Jun 7, 2023
- Notices
- Combined Synopsis/Solicitation posted Jun 7, 2023
Contract details
- Subcontracting plan
- Plan not requiredB
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jul 17, 2023Base obligation at award: $65,500
- Latest action
- Oct 25, 2023 — Supplemental agreement (within scope)Modification P00001; obligation change -$10,800
- Latest substantive action
- Oct 25, 2023 — Supplemental agreement (within scope)Modification P00001; obligation change -$10,800
- Actions by type
- Base award1
- Supplemental agreement (within scope)1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$10,800
- Latest action: change in base and all options
- -$10,800
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- Foreign-owned business incorporated in the U.S.C
- Country of product or service origin
- ChinaCHN
- Place of manufacture
- Mfg outside U.S. - domestic nonavailabilityJ
Structure
- Award or IDV
- Award
- Award type
- Purchase orderB
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N950
- Transactions recorded under this award key
- 2
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N95C
- Treasury accounts
- 075-2023/2023-0875-000
- Object classes
- 26.0: Supplies and materials
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression